Alkermes (ALKS) Current Deferred Revenue (2011 - 2025)
Alkermes (ALKS) reported Current Deferred Revenue of $578000.0 for Q2 2025, down 82.54% year-over-year from $3.3 million in Q2 2024, and down 64.08% quarter-over-quarter from $1.6 million in Q1 2025.
Alkermes (ALKS) Current Deferred Revenue (2011 - 2025) Analysis & Trends
Alkermes (ALKS) has 15 years of Current Deferred Revenue data on file, last reported at $578000.0 in Q2 2025.
- Current Deferred Revenue for Q2 2025 came in at $578000.0, down 82.54% year-over-year; the trailing twelve-month figure through Jun 2025 was $578000.0 (down 82.54% YoY), and the FY2024 annual result was $1.2 million, down 73.84% from the prior year.
- Current Deferred Revenue declined to $578000.0 in Q2 2025 per ALKS's latest filing, from $1.6 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $17.8 million in Q4 2021 and troughed at $578000.0 in Q2 2025.
- A 5-year average of $5.6 million and a median of $4.8 million in 2022 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue soared 34.9% in 2022, then plunged 82.54% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $17.8 million in 2021, then slumped by 39.98% to $10.7 million in 2022, then sank by 55.38% to $4.8 million in 2023, then slumped by 73.84% to $1.2 million in 2024, then sank by 53.72% to $578000.0 in 2025.
- Business Quant data shows ALKS's Current Deferred Revenue at $578000.0 in Q2 2025, $1.6 million in Q1 2025, and $1.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 578,000.00 |
| Mar 31, 2025 | 1.61 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 2.34 Mn |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 4.57 Mn |
| Dec 31, 2023 | 4.78 Mn |
| Sep 30, 2023 | 4.98 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 10.70 Mn |
| Sep 30, 2022 | 8.64 Mn |
| Jun 30, 2022 | 3.79 Mn |
| Mar 31, 2022 | 4.92 Mn |
| Dec 31, 2021 | 17.83 Mn |
| Sep 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 6.63 Mn |
| Mar 31, 2021 | 7.92 Mn |
| Dec 31, 2020 | 23.91 Mn |
| Sep 30, 2020 | 25.79 Mn |